Preferred Label : glucagon-like peptide 1;
Origin ID : F-B6330;
UMLS CUI : C0061355;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- SNOMED CT concept
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.cochrane.org/fr/CD015849/CENTRALED_le-traitement-par-agonistes-des-recepteurs-du-glp-1-previent-il-les-complications-chez-les-personnes
2025
United Kingdom
review of literature
french abstract
renal insufficiency, chronic
kidney diseases
diabetes with renal manifestations
Glucagon-Like Peptide-1 Receptor
diabetic complications
glucagon-like peptide 1
chronic disease
chronic disease, nos
kidney disease, nos
receptors, interleukin-1
diabetes complications
diabetic nephropathies
persons
---
https://www.acadpharm.org/publications/page.php?rb1=50&id_doc=7184
2024
France
scientific and technical information
parkinson's disease, nos
Intensity and Distress 1
One
Fear Score 1
Histone-Lysine N-Methyltransferase EHMT1
CDISC SDTM Model Version 1.5
Agreement Score 1
Thought Score 1
Symptoms Extent Score 1
Guadeloupe
Phase I Trial
Upset Score 1
Glucagon-Like Peptide-1 Receptor
Severity of Symptom Score 1
Mild Adverse Event
One Hundred Percent
One Full Term Pregnancy
Illness Intrusiveness Rating 1
Parkinson's Disease Pathway KEGG
glucagon-like peptide 1
Never Smoker
Parkinson Disease
Gleason Grade Group 1
ECOG Performance Status 1
Receptor
Neck Pain Score 1
What Month is it Question
1+ Score, WHO
1+ Score
CDISC SDTM Model Version 1.6
Tumor Regression Score 1
Clinical Status Ordinal Scale Outcome 1
parkinson disease
---
https://minerva-ebp.be/FR/Article/2237
2021
false
false
false
Belgium
critical appraisal or critical reading
Adult
body weight
semaglutide
Diabetes
diabetes mellitus
exercise
glucagon-like peptide 1
dietetics
association
adulthood
nutritionists
measures
Adult
semaglutide
overweight
glucagon-like peptide 1
adult
diabetes mellitus, nos
weights and measures
---
https://www.cochrane.org/fr/CD013650/VASC_les-effets-des-inhibiteurs-de-la-dpp-4-des-agonistes-des-recepteurs-du-glp-1-et-des-inhibiteurs-du
2021
United Kingdom
review of literature
french abstract
glucagon-like peptide 1
Glucagon-Like Peptide-1 Receptor
cardiovascular diseases
disease
Glucagon-Like Peptide-2 Receptor
persons
glucagon-like peptide 2
Diseases of the cardiovascular system
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Diseases
Disease
premature separation of placenta
disease of cardiovascular system, nos
---
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/Gueritee/Guer2012/2012as.pdf
2012
France
scientific and technical information
orientation
dipeptidyl-peptidase iv inhibitors
orientation, nos
hospitals, proprietary
Glucagon-Like Peptide-1 Receptor
premature separation of placenta
glucagon-like peptide 1
endocrinology
choice behavior
---
